Showing results (1-10 of 419) with videos related to
Sort By:
Pageof 42
Ugeskrift for Laeger|July 21, 1999
[Angiogenesis: prognostic marker in prostatic cancer]M Borre, I B Offersen, B Nerstrøm, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waitingM Borre, B Nerstrøm, J OvergaardUgeskrift for Laeger|April 21, 1997
[Prostatic cancer: an expensive dilemma]M Borre, B Nerstrøm, J OvergaardCancer|November 5, 1997
The natural history of prostate carcinoma based on a Danish population treated with no intent to cureM Borre, B Nerstrøm, J OvergaardActa Oncologica (Stockholm, Sweden)|January 1, 1997
The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategiesM Borre, B Nerstrøm, J OvergaardActa Oncologica (Stockholm, Sweden)|January 1, 1997
Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancerM Borre, B Nerstrøm, J OvergaardThe Prostate|August 27, 1998
DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cureM Borre, M Høyer, B Nerstrøm, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantlyM Borre, B Stausbøl-Grøn, B Nerstrøm, et al.British Journal of Cancer|October 9, 1998
Microvessel density predicts survival in prostate cancer patients subjected to watchful waitingM Borre, B V Offersen, B Nerstrøm, et al.The Journal of Urology|April 29, 1998
Tumor cell proliferation and survival in patients with prostate cancer followed expectantlyM Borre, S M Bentzen, B Nerstrøm, et al.Pageof 42